New drug
Details for Australian Patent Application No. 2002326277 (hide)
International Classifications
Event Publications
23 January 2003 Complete Application Filed
Priority application(s): 0102823-2 24.08.01 SE; 60/314,971 24.08.01 US
5 June 2003 Application Open to Public Inspection
Published as AU-B-2002326277
16 December 2004 Assignment before Grant
Stromblad, Staffan; Kogerman, Priit; Pall, Taari The application has been assigned to Angitia AB Assignments before Grant, Section 113
4 October 2007 Application Accepted
Published as AU-B-2002326277
31 January 2008 Standard Patent Sealed
24 April 2008 Assignment Registered
Angitia AB The patent has been assigned to Celecure AS
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002326276-N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser